Abstract: The present disclosure relates to the technical field of wastewater treatment, and provides a wastewater treatment method and apparatus based on hydrate-based water vapor adsorption. The apparatus includes a wastewater evaporation zone, a hydrate formation zone, a hydrate decomposition zone, and a data acquisition and control system. Rising water vapor and condensed water formed during evaporation of wastewater at normal temperature react with a hydrate former on a cooling wall surface to form a hydrate, continuous evaporation of the wastewater is promoted, the hydrate is scraped off to a collecting zone below by a scraper after being formed, and the hydrate is decomposed into fresh water, thereby realizing wastewater treatment. The present disclosure provides a method for treating complex wastewater containing a plurality of pollutants, where water vapor is consumed to form the hydrate to promote wastewater evaporation, and water obtained from the decomposition does not contain pollutants theoretically.

Abstract: The present disclosure discloses a natural pharmaceutical composition for treating osteoporotic fracture and/or osteoarthritis and an application thereof. The composition is composed of 73.3 wt %-98.3 wt % of sea buckthorn pulp oil and 1.7 wt %-26.7 wt % of panax notoginseng saponins. The composition can be further used for preventing and treating ostealgia diseases.

Abstract: The present disclosure discloses a pharmaceutical composition for treating menopausal mental depression and atypical depressive disorder and an application thereof. The composition is composed of the following components in percentage by mass: 70%-97.5% of sea buckthorn pulp oil and 2.5%-30% of total panax notoginseng saponins from stem and leave. The application is use of the pharmaceutical composition for preparing drugs and/or health care products used for treating menopause, the menopausal mental depression or the atypical depressive disorder.

Abstract: The present disclosure discloses a natural pharmaceutical composition for treating osteoporotic fracture and/or osteoarthritis and an application thereof. The composition is composed of 73.3 wt %-98.3 wt % of sea buckthorn pulp oil and 1.7 wt %-26.7 wt % of panax notoginseng saponins. The composition can be further used for preventing and treating ostealgia diseases.